---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-27T14:11:48.759973'
end_time: '2025-12-27T14:20:04.148898'
duration_seconds: 495.39
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: MAP7D2
  gene_symbol: MAP7D2
  uniprot_accession: Q96T17
  protein_description: 'RecName: Full=MAP7 domain-containing protein 2;'
  gene_info: Name=MAP7D2;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the MAP7 family. .
  protein_domains: MAP7_domain-containing. (IPR051483); MAP7_fam. (IPR008604); MAP7
    (PF05672)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 17
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q96T17
- **Protein Description:** RecName: Full=MAP7 domain-containing protein 2;
- **Gene Information:** Name=MAP7D2;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the MAP7 family. .
- **Key Domains:** MAP7_domain-containing. (IPR051483); MAP7_fam. (IPR008604); MAP7 (PF05672)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "MAP7D2" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'MAP7D2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **MAP7D2** (gene ID: MAP7D2, UniProt: Q96T17) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q96T17
- **Protein Description:** RecName: Full=MAP7 domain-containing protein 2;
- **Gene Information:** Name=MAP7D2;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the MAP7 family. .
- **Key Domains:** MAP7_domain-containing. (IPR051483); MAP7_fam. (IPR008604); MAP7 (PF05672)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "MAP7D2" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'MAP7D2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **MAP7D2** (gene ID: MAP7D2, UniProt: Q96T17) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research report: MAP7D2 (UniProt Q96T17) – functional annotation and recent evidence

Verification of identity and family/domains
- Target identity: MAP7 domain-containing protein 2 (gene symbol MAP7D2) in Homo sapiens, a member of the MAP7/ensconsin family. Conserved architecture across MAP7 paralogs includes an N-terminal microtubule-binding region and a C-terminal kinesin-1–interacting region, consistent with MAP7 family domain organization and function. Neuronal studies identify MAP7D2 as the paralog concentrated at the proximal axon. These features align with the UniProt description and MAP7-family domain expectations (N-terminal MAP7 domain; MAP7 family). Evidence: in neurons, MAP7D2’s N-terminus binds microtubules; its C-terminus underlies kinesin-1 interaction, mirroring MAP7-family domain logic (Pan et al., Cell Reports, 2019; Kikuchi et al., Life Science Alliance preprint, 2022; Hooikaas et al., J Cell Biol, 2019) (pan2019map7d2localizesto pages 1-4, kikuchi2022map7d2andmap7d1 pages 4-7, hooikaas2019map7familyproteins pages 6-10).

Key concepts and definitions
- Molecular class: Microtubule-associated protein (MAP) of the MAP7 family. MAP7 family proteins act as microtubule-tethered activators that recruit and enhance kinesin-1 motility on microtubules. Mechanistically, MAP7-family members both promote kinesin-1 landing and increase processivity through direct and allosteric effects (Hooikaas et al., Feb 15, 2019; URL: https://doi.org/10.1083/jcb.201808065) (hooikaas2019map7familyproteins pages 6-10).
- Primary cellular role of MAP7D2: Local regulator of kinesin-1 at the proximal axon/axon initial segment (AIS), promoting kinesin-1–mediated cargo entry into the axon and influencing axon development and polarized transport (Pan et al., Feb 19, 2019; URL: https://doi.org/10.1016/j.celrep.2019.01.084) (pan2019map7d2localizesto pages 1-4, pan2019map7d2localizesto pages 10-12).

Molecular function and mechanism
- Microtubule binding and stabilization: MAP7D2 directly binds microtubules via its N-terminal half and stabilizes microtubules. In neuronal cell models, MAP7D2 loss reduces nocodazole resistance (indicative of reduced MT stability) and increases neurite outgrowth and random migration, consistent with a role in tempering MT dynamics (Kikuchi et al., posted Mar 2, 2022; URL: https://doi.org/10.1101/2021.10.27.466197) (kikuchi2022map7d2andmap7d1 pages 4-7, kikuchi2022map7d2andmap7d1 pages 1-4, kikuchi2022map7d2andmap7d1 pages 38-38).
- Kinesin-1 interaction and activation: MAP7D2 interacts with kinesin-1 family members (KIF5A/B/C) and promotes their recruitment/activity on microtubules, gating anterograde transport into the axon. Depletion of MAP7D2 reduces kinesin-1–dependent axonal entry of multiple organelle cargos and alters KIF5 distribution at the axon start (Pan et al., 2019; URL: https://doi.org/10.1016/j.celrep.2019.01.084) (pan2019map7d2localizesto pages 10-12, pan2019map7d2localizesto pages 6-8, pan2019map7d2localizesto pages 1-4).
- Distinct mechanism within MAP7 family: Compared with MAP7D1, MAP7D2 stabilizes microtubules primarily through direct binding rather than maintaining acetylated tubulin; both can form complexes with Kif5b, but their stabilization mechanisms diverge (Kikuchi et al., 2022; URL: https://doi.org/10.1101/2021.10.27.466197) (kikuchi2022map7d2andmap7d1 pages 9-12, kikuchi2022map7d2andmap7d1 pages 4-7, kikuchi2022map7d2andmap7d1 pages 38-38).

Cellular localization
- Proximal axon/AIS enrichment: MAP7D2 concentrates at the proximal axon (overlapping the AIS region) in developing hippocampal neurons, positioning it to modulate the axonal transport gate (Pan et al., 2019; URL: https://doi.org/10.1016/j.celrep.2019.01.084) (pan2019map7d2localizesto pages 1-4, pan2019map7d2localizesto pages 10-12).
- Additional subcellular sites: In neuronal cell lines, MAP7D2 is prominent at centrosomes and partially along microtubules; accumulates in neurites and at the midbody during cytokinesis (Kikuchi et al., 2022; URL: https://doi.org/10.1101/2021.10.27.466197) (kikuchi2022map7d2andmap7d1 pages 7-9).

Pathway context and biological processes
- Axon polarity and transport gating: By locally recruiting/activating kinesin-1 on proximal-axon microtubules, MAP7D2 facilitates polarized entry of cargoes (mitochondria, lysosomes, ER-derived organelles) into axons, thereby contributing to axon formation, branching, and neuronal migration (Pan et al., 2019; URL: https://doi.org/10.1016/j.celrep.2019.01.084) (pan2019map7d2localizesto pages 1-4, pan2019map7d2localizesto pages 10-12, pan2019map7d2localizesto pages 6-8).
- MAP7 family in transport regulation: Broadly, MAP7 paralogs regulate kinesin-1 landing and processivity; MAP7D3 shows higher kinesin-1 affinity and mobility than MAP7, illustrating paralog-specific modulation of kinesin mechanics (Hooikaas et al., 2019; URL: https://doi.org/10.1083/jcb.201808065) (hooikaas2019map7familyproteins pages 6-10).

Recent developments and latest research (emphasis 2023–2024)
- Human genetics (2023): An X-chromosome GWAS in UK Biobank identified MAP7D2 as significantly associated with age-related hearing loss (lead variant rs4370706 p = 2.3×10−8; combined OR ~1.03), with supporting expression in mouse and adult human inner ear tissues, particularly inner hair cells (Naderi et al., Feb 21, 2023; URL: https://doi.org/10.3389/fgene.2023.1106328) (naderi2023thegeneticcontribution pages 1-2, naderi2023thegeneticcontribution pages 4-6).
- Kinesin regulation framework (continuing relevance): Mechanistic principles of MAP7-family regulation of kinesin-1 recruitment/activation remain foundational for interpreting MAP7D2’s axonal gate role (Hooikaas et al., 2019; URL: https://doi.org/10.1083/jcb.201808065) (hooikaas2019map7familyproteins pages 6-10).

Current applications and real-world implementations
- Genetic association and inner ear biology: The MAP7D2 ARHL association supports follow-up functional studies in sensory hair cells and could inform risk stratification or mechanistic studies of cochlear transport and homeostasis (Naderi et al., 2023; URL: https://doi.org/10.3389/fgene.2023.1106328) (naderi2023thegeneticcontribution pages 1-2, naderi2023thegeneticcontribution pages 4-6).
- Oncology transcriptomics: Analyses of public NSCLC datasets report MAP7D2 mRNA upregulation in lung cancer tissues (e.g., 5.45-fold in a large-cell carcinoma dataset, p = 1.33×10−6; 6.79-fold in a lung adenocarcinoma dataset, p = 4.31×10−11), with broader exploration of MAPs in prognosis and immunotherapy response. While MAP7D2 itself showed limited prognostic association in that study, elevated expression supports its use as a transcriptomic variable in lung cancer research (Luo et al., Oct 27, 2021; URL: https://doi.org/10.3389/fonc.2021.680402) (luo2021expressionofmicrotubuleassociated pages 5-9).

Expert opinions and analysis from authoritative sources
- JCB mechanistic study: Hooikaas et al. propose MAP7 proteins as microtubule-tethered kinesin-1 activators, acting through both direct MT tethering and an allosteric kinesin-1–binding C-terminus. This dual mechanism rationalizes how MAP7D2 could locally bias kinesin-1 engagement in the proximal axon (Hooikaas et al., 2019; URL: https://doi.org/10.1083/jcb.201808065) (hooikaas2019map7familyproteins pages 6-10).
- Cell Reports neuronal study: Pan et al. argue that MAP7D2 functions specifically at the proximal axon to promote kinesin-1–mediated cargo entry and axon development, establishing a localized transport control point integral to neuronal polarity (Pan et al., 2019; URL: https://doi.org/10.1016/j.celrep.2019.01.084) (pan2019map7d2localizesto pages 1-4, pan2019map7d2localizesto pages 10-12).
- MAP7D2 stabilization mechanism: Kikuchi et al. highlight paralog-specific MT stabilization mechanisms, with MAP7D2 acting via direct MT binding and MAP7D1 supporting acetylated MTs—an important nuance for interpreting phenotypes across tissues and contexts (Kikuchi et al., 2022; URL: https://doi.org/10.1101/2021.10.27.466197) (kikuchi2022map7d2andmap7d1 pages 9-12, kikuchi2022map7d2andmap7d1 pages 4-7, kikuchi2022map7d2andmap7d1 pages 38-38).

Relevant statistics and quantitative data
- GWAS (ARHL, X chromosome): Lead MAP7D2 variant rs4370706 reached genome-wide significance (p = 2.3×10−8). X-chromosome variants collectively explained ~0.4% of ARHL variance in the dataset (SE 0.8%, p = 3.5×10−6). Reported combined OR for MAP7D2 locus ~1.03 (95% CI 1.016–1.045). Expression evidence included mouse inner ear and adult human inner ear (Naderi et al., 2023; URL: https://doi.org/10.3389/fgene.2023.1106328) (naderi2023thegeneticcontribution pages 1-2, naderi2023thegeneticcontribution pages 4-6).
- Cancer transcriptomics (NSCLC datasets): MAP7D2 mRNA fold-change upregulation reported as 5.453 (p = 1.33×10−6; Hou Lung dataset) and 6.785 (p = 4.31×10−11; Okayama Lung) relative to normal tissues (Luo et al., 2021; URL: https://doi.org/10.3389/fonc.2021.680402) (luo2021expressionofmicrotubuleassociated pages 5-9).
- Biochemical/biophysical (MAP7D2 MT binding): Microtubule co-sedimentation determined an apparent KD on the order of ~6×10−7 M and a binding stoichiometry of approximately one MAP7D2 per ~10 α/β-tubulin heterodimers for recombinant protein in vitro (Kikuchi et al., 2022; URL: https://doi.org/10.1101/2021.10.27.466197) (kikuchi2022map7d2andmap7d1 pages 4-7).
- Cell biological readouts (neurons): MAP7D2 depletion reduced KIF5C intensity at the axon start and diminished axonal entry of organelle cargos; sample sizes per condition ranged roughly from n ≈ 15–32 neurons with statistical significance thresholds noted (Pan et al., 2019; URL: https://doi.org/10.1016/j.celrep.2019.01.084) (pan2019map7d2localizesto pages 10-12).

Notes on symbol specificity and organism
- Ambiguity check: MAP7D2 can refer to different species’ orthologs in publications. The human identity (UniProt Q96T17) aligns with the MAP7 family architecture described above. Much mechanistic work (Pan et al., Kikuchi et al.) used rodent neuronal systems to elucidate a conserved function that is consistent with human MAP7D2 domain structure and the family’s kinesin-1–modulatory role. No conflicting gene of the same symbol in a different organism was identified that would invalidate the human MAP7D2 context considered here (pan2019map7d2localizesto pages 1-4, kikuchi2022map7d2andmap7d1 pages 4-7).

Summary
- MAP7D2 is a human MAP7-family microtubule-associated protein localized to the proximal axon/AIS, where it recruits/activates kinesin-1 to promote anterograde cargo entry, contributing to axon development and polarized transport. It directly binds and stabilizes microtubules via its N-terminus and associates with kinesin-1 via its conserved C-terminus. Recent human genetics implicate MAP7D2 in age-related hearing loss, supported by inner-ear expression. Cancer transcriptomics report MAP7D2 upregulation in NSCLC datasets, though prognostic impact for MAP7D2 itself is limited in that study. Together, these data support a core role for MAP7D2 in microtubule-based transport gating at the proximal axon with disease relevance emerging in sensory hearing biology and oncology transcriptomics (Pan 2019: https://doi.org/10.1016/j.celrep.2019.01.084; Hooikaas 2019: https://doi.org/10.1083/jcb.201808065; Kikuchi 2022: https://doi.org/10.1101/2021.10.27.466197; Naderi 2023: https://doi.org/10.3389/fgene.2023.1106328; Luo 2021: https://doi.org/10.3389/fonc.2021.680402) (pan2019map7d2localizesto pages 1-4, hooikaas2019map7familyproteins pages 6-10, kikuchi2022map7d2andmap7d1 pages 4-7, naderi2023thegeneticcontribution pages 1-2, luo2021expressionofmicrotubuleassociated pages 5-9).

References

1. (pan2019map7d2localizesto pages 1-4): Xingxiu Pan, Yujie Cao, Riccardo Stucchi, Peter Jan Hooikaas, Sybren Portegies, Lena Will, Maud Martin, Anna Akhmanova, Martin Harterink, and Casper C. Hoogenraad. Map7d2 localizes to the proximal axon and locally promotes kinesin-1-mediated cargo transport into the axon. Cell Reports, 26:1988-1999.e6, Feb 2019. URL: https://doi.org/10.1016/j.celrep.2019.01.084, doi:10.1016/j.celrep.2019.01.084. This article has 52 citations and is from a highest quality peer-reviewed journal.

2. (kikuchi2022map7d2andmap7d1 pages 4-7): Koji Kikuchi, Yasuhisa Sakamoto, Akiyoshi Uezu, Hideyuki Yamamoto, Kei-ichiro Ishiguro, Kenji Shimamura, Taro Saito, Shin-ichi Hisanaga, and Hiroyuki Nakanishi. Map7d2 and map7d1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells. Life Science Alliance, Mar 2022. URL: https://doi.org/10.1101/2021.10.27.466197, doi:10.1101/2021.10.27.466197. This article has 1 citations and is from a peer-reviewed journal.

3. (hooikaas2019map7familyproteins pages 6-10): Peter Jan Hooikaas, Maud Martin, Tobias Mühlethaler, Gert-Jan Kuijntjes, Cathelijn A.E. Peeters, Eugene A. Katrukha, Luca Ferrari, Riccardo Stucchi, Daan G.F. Verhagen, Wilhelmina E. van Riel, Ilya Grigoriev, A.F. Maarten Altelaar, Casper C. Hoogenraad, Stefan G.D. Rüdiger, Michel O. Steinmetz, Lukas C. Kapitein, and Anna Akhmanova. Map7 family proteins regulate kinesin-1 recruitment and activation. Journal of Cell Biology, 218:1298-1318, Feb 2019. URL: https://doi.org/10.1083/jcb.201808065, doi:10.1083/jcb.201808065. This article has 170 citations and is from a highest quality peer-reviewed journal.

4. (pan2019map7d2localizesto pages 10-12): Xingxiu Pan, Yujie Cao, Riccardo Stucchi, Peter Jan Hooikaas, Sybren Portegies, Lena Will, Maud Martin, Anna Akhmanova, Martin Harterink, and Casper C. Hoogenraad. Map7d2 localizes to the proximal axon and locally promotes kinesin-1-mediated cargo transport into the axon. Cell Reports, 26:1988-1999.e6, Feb 2019. URL: https://doi.org/10.1016/j.celrep.2019.01.084, doi:10.1016/j.celrep.2019.01.084. This article has 52 citations and is from a highest quality peer-reviewed journal.

5. (kikuchi2022map7d2andmap7d1 pages 1-4): Koji Kikuchi, Yasuhisa Sakamoto, Akiyoshi Uezu, Hideyuki Yamamoto, Kei-ichiro Ishiguro, Kenji Shimamura, Taro Saito, Shin-ichi Hisanaga, and Hiroyuki Nakanishi. Map7d2 and map7d1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells. Life Science Alliance, Mar 2022. URL: https://doi.org/10.1101/2021.10.27.466197, doi:10.1101/2021.10.27.466197. This article has 1 citations and is from a peer-reviewed journal.

6. (kikuchi2022map7d2andmap7d1 pages 38-38): Koji Kikuchi, Yasuhisa Sakamoto, Akiyoshi Uezu, Hideyuki Yamamoto, Kei-ichiro Ishiguro, Kenji Shimamura, Taro Saito, Shin-ichi Hisanaga, and Hiroyuki Nakanishi. Map7d2 and map7d1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells. Life Science Alliance, Mar 2022. URL: https://doi.org/10.1101/2021.10.27.466197, doi:10.1101/2021.10.27.466197. This article has 1 citations and is from a peer-reviewed journal.

7. (pan2019map7d2localizesto pages 6-8): Xingxiu Pan, Yujie Cao, Riccardo Stucchi, Peter Jan Hooikaas, Sybren Portegies, Lena Will, Maud Martin, Anna Akhmanova, Martin Harterink, and Casper C. Hoogenraad. Map7d2 localizes to the proximal axon and locally promotes kinesin-1-mediated cargo transport into the axon. Cell Reports, 26:1988-1999.e6, Feb 2019. URL: https://doi.org/10.1016/j.celrep.2019.01.084, doi:10.1016/j.celrep.2019.01.084. This article has 52 citations and is from a highest quality peer-reviewed journal.

8. (kikuchi2022map7d2andmap7d1 pages 9-12): Koji Kikuchi, Yasuhisa Sakamoto, Akiyoshi Uezu, Hideyuki Yamamoto, Kei-ichiro Ishiguro, Kenji Shimamura, Taro Saito, Shin-ichi Hisanaga, and Hiroyuki Nakanishi. Map7d2 and map7d1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells. Life Science Alliance, Mar 2022. URL: https://doi.org/10.1101/2021.10.27.466197, doi:10.1101/2021.10.27.466197. This article has 1 citations and is from a peer-reviewed journal.

9. (kikuchi2022map7d2andmap7d1 pages 7-9): Koji Kikuchi, Yasuhisa Sakamoto, Akiyoshi Uezu, Hideyuki Yamamoto, Kei-ichiro Ishiguro, Kenji Shimamura, Taro Saito, Shin-ichi Hisanaga, and Hiroyuki Nakanishi. Map7d2 and map7d1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells. Life Science Alliance, Mar 2022. URL: https://doi.org/10.1101/2021.10.27.466197, doi:10.1101/2021.10.27.466197. This article has 1 citations and is from a peer-reviewed journal.

10. (naderi2023thegeneticcontribution pages 1-2): Elnaz Naderi, Diana M. Cornejo-Sanchez, Guangyou Li, Isabelle Schrauwen, Gao T. Wang, Andrew T. Dewan, and Suzanne M. Leal. The genetic contribution of the x chromosome in age-related hearing loss. Frontiers in Genetics, Feb 2023. URL: https://doi.org/10.3389/fgene.2023.1106328, doi:10.3389/fgene.2023.1106328. This article has 3 citations and is from a peer-reviewed journal.

11. (naderi2023thegeneticcontribution pages 4-6): Elnaz Naderi, Diana M. Cornejo-Sanchez, Guangyou Li, Isabelle Schrauwen, Gao T. Wang, Andrew T. Dewan, and Suzanne M. Leal. The genetic contribution of the x chromosome in age-related hearing loss. Frontiers in Genetics, Feb 2023. URL: https://doi.org/10.3389/fgene.2023.1106328, doi:10.3389/fgene.2023.1106328. This article has 3 citations and is from a peer-reviewed journal.

12. (luo2021expressionofmicrotubuleassociated pages 5-9): Jieyan Luo, Qipeng Hu, Maling Gou, Xiaoke Liu, Yi Qin, Jiao Zhu, Chengzhi Cai, Tian Tian, Zegui Tu, Yijia Du, and Hongxin Deng. Expression of microtubule-associated proteins in relation to prognosis and efficacy of immunotherapy in non-small cell lung cancer. Frontiers in Oncology, Oct 2021. URL: https://doi.org/10.3389/fonc.2021.680402, doi:10.3389/fonc.2021.680402. This article has 23 citations and is from a poor quality or predatory journal.

## Citations

1. luo2021expressionofmicrotubuleassociated pages 5-9
2. naderi2023thegeneticcontribution pages 1-2
3. naderi2023thegeneticcontribution pages 4-6
4. https://doi.org/10.1083/jcb.201808065
5. https://doi.org/10.1016/j.celrep.2019.01.084
6. https://doi.org/10.1101/2021.10.27.466197
7. https://doi.org/10.3389/fgene.2023.1106328
8. https://doi.org/10.3389/fonc.2021.680402
9. https://doi.org/10.1016/j.celrep.2019.01.084;
10. https://doi.org/10.1083/jcb.201808065;
11. https://doi.org/10.1101/2021.10.27.466197;
12. https://doi.org/10.3389/fgene.2023.1106328;
13. https://doi.org/10.1016/j.celrep.2019.01.084,
14. https://doi.org/10.1101/2021.10.27.466197,
15. https://doi.org/10.1083/jcb.201808065,
16. https://doi.org/10.3389/fgene.2023.1106328,
17. https://doi.org/10.3389/fonc.2021.680402,